In our study, the TP53 p.V197E mutation is located within the DNA binding domain and may contribute to ESCC progression, an observation that accounts for the improper DNA binding and disruption of transcriptional activity that was observed. Here, TP53 is linked to esophageal squamous cell carcinoma.